Citations

Showing 10 of 108094 citations.

Toward an effective peripheral visceral analgesic: responding to the national opioid crisis
Camilleri, Michael

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | February 22, 2018 | Volume: 314 | Issue: 6 | Pages: G637-G646

10.1152/ajpgi.00013.2018 | PMID 29470146 Get It

This mini-review summarizes recent new developments in visceral analgesics. This promising field is important, as a new approach to address abdominal pain with peripheral visceral analgesics is considered a key approach to addressing the current opioid crisis. Some of the novel compounds address peripheral pain mechanisms through modulation of opioid receptors via biased ligands, nociceptin/orphanin FQ opioid peptide (NOP) receptor, or dual action on NOP and μ-opioid receptor, buprenorphine and morphiceptin analogs. Other compounds target nonopioid mechanisms, including cannabinoid (CB2), N-methyl-d-aspartate, calcitonin gene-related peptide, estrogen, and adenosine A2Breceptors and transient receptor potential (TRP) channels (TRPV1, TRPV4, and TRPM8). Although current evidence is based predominantly on animal models of visceral pain, early human studies also support the evidence from the basic and animal research. This augurs well for the development of nonaddictive, visceral analgesics for treatment of chronic abdominal pain, an unmet clinical need.
Whole Exome Sequencing and Molecular Modeling of a Missense Variant in TNFAIP3 That Segregates with Disease in a Family with Chronic Urticaria and Angioedema
Harris, Antoneicka L., Blackburn, Patrick R. , Richter, John E. , Gass, Jennifer , Mohammad, Ahmed N. , Atwal, Paldeep S. , Caulfield, Thomas R , Atwal, Paldeep S , Caulfield, Thomas R.

Mayo Clinic

Case Reports in Genetics | February 22, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-6

10.1155/2018/6968395 | PMID 29682366 Get It

Chronic urticaria is a common condition characterized by recurrent hives lasting several weeks or months and is usually idiopathic. Approximately half of the individuals with chronic urticaria will present with episodes of angioedema that can be severe and debilitating. In this report, we describe a 47-year-old Hispanic male who presented initially for an evaluation of chronic hives following hospitalization due to hive-induced anaphylaxis. The individual had a history significant for urticaria and angioedema beginning in his early 30s. Interestingly, both the individual’s 41-year-old sister and 12-year-old daughter were also affected with chronic urticaria and severe angioedema. Whole exome sequencing of the proband and several family members revealed a heterozygous variant of uncertain significance in exon 2 of TNFAIP3, denoted as c.65G>A (p.R22Q), in all affected members. Variants in TNFAIP3 have been associated with multiple autoimmune diseases, susceptibility to allergy and asthma, and periodic fever syndromes, suggesting that this variant could potentially play a role in disease.
Reply to Babbel et al., “Application of the DRIP Score at a Veterans Affairs Hospital”
Webb, Brandon , Stenehjem, Eddie, Dascomb, Kristin , Vikram, Holenarasipur R. , Dean, Nathan C. , Stenehjem, Edward , Webb, Brandon J , Vikram, Holenarasipur R. , Metersky, Mark L.

Mayo Clinic

Antimicrobial Agents and Chemotherapy | February 22, 2018 | Volume: 62 | Issue: 3 | Pages: No page available

10.1128/aac.02337-17 | PMID 29475893 Get It

Erdheim–Chester disease: description of two illustrative cases involving the lung
Zanelli, Magda , Mengoli, Maria Cecilia , Spaggiari, Lucia, Marco, Loredana De , Ascani, Stefano , Mengoli, Maria C , Smith, Maxwell L. , Lococo, Filippo , Puma, Francesco

Mayo Clinic

Histopathology | February 22, 2018 | Volume: 73 | Issue: 1 | Pages: 167-172

10.1111/his.13501 | PMID 29469219 Get It

AimErdheim–Chester disease represents a clonal systemic proliferation of histiocytes. Bone is the most common site of involvement, although almost any organ, including the lungs, can be affected.Methods and resultsThe diagnosis of Erdheim–Chester disease can be difficult, owing to its rarity and protean presentation. Correlation between clinical, radiological and histological findings is mandatory for identification of the disease. Foamy histiocytes, lacking Langerhans cell markers, represent the typical histological findings, although their absence does not rule out Erdheim–Chester disease. Identification of BRAF mutation can be helpful in making the diagnosis, and allows for the development and application of targeted therapies in this setting.ConclusionsHerein, we describe two cases presenting with lung involvement and vertebral lesions, lacking the more typical long‐bone involvement. One case histologically mimicked Rosai–Dorfman disease. However, both cases harboured the pathognomonic BRAFV600E mutation.
The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Kazemi, Arash , McLaren, Jay W. , Kopczynski, Casey , Heah, Theresa, Novack, Gary D. , Sit, Arthur J. , Sit, Arthur J

Mayo Clinic

Journal of Ocular Pharmacology and Therapeutics | February 22, 2018 | Volume: 34 | Issue: 5 | Pages: 380-386

10.1089/jop.2017.0138 | PMID 29469601 Get It

Aging and anatomical variations in lung tissue stiffness
Sicard, Delphine , Haak, Andrew J. , Choi, Kyoung Moo , Craig, Alexandria R., Fredenburgh, Laura E. , Tschumperlin, Daniel J.

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | February 22, 2018 | Volume: 314 | Issue: 6 | Pages: L946-L955

10.1152/ajplung.00415.2017 | PMID 29469613 Get It

Lung function is inherently mechanical in nature and depends on the capacity to conduct air and blood to and from the gas exchange regions. Variations in the elastic properties of the human lung across anatomical compartments and with aging are likely important determinants of lung function but remain relatively poorly characterized. Here we applied atomic force microscopy microindentation to characterize human lung tissue from subjects ranging in age from 11 to 60 yr old. We observed striking anatomical variations in elastic modulus, with the airways (200- to 350-µm diameter) the stiffest and the parenchymal regions the most compliant. Vessels (diameter < 100 µm) represented an intermediate mechanical environment and displayed diameter-dependent trends in elastic modulus. Binning our samples into younger (11–30 yr old) and older (41–60 yr old) groups, we observed significant age-related increases in stiffness in parenchymal and vessel compartments, with the most pronounced changes in the vessels. To investigate cellular mechanisms that might contribute to vascular stiffening with aging, we studied primary human pulmonary artery smooth muscle cells from subjects ranging in age from 11 to 60 yr old. While we observed no change in the mechanical properties of the cells themselves, we did observe trends toward increases in traction forces and extracellular matrix deposition with aging. These results demonstrate age-related changes in tissue mechanical properties that likely contribute to impaired lung function with aging and underscore the potential to identify mechanisms that contribute to mechanical tissue remodeling through the study of human cells and tissues from across the aging spectrum.
Image guidance doses delivered during radiotherapy: Quantification, management, and reduction: Report of the AAPM Therapy Physics Committee Task Group 180
Ding, G , Alaei, Parham , Curran, Bruce, Flynn, Ryan T. , Gossman, Michael S., Mackie, T, Miften, Moyed, Morin, Richard L. , Xu, Xiaobin , Morin, Richard, Zhu, Timothy C. , Flynn, Ryan T

Mayo Clinic

Medical Physics | February 22, 2018 | Volume: 45 | Issue: 5 | Pages: No page available

10.1002/mp.12824 | PMID 29468678 Get It

BackgroundWith radiotherapy having entered the era of image guidance, or image‐guided radiation therapy (IGRT), imaging procedures are routinely performed for patient positioning and target localization. The imaging dose delivered may result in excessive dose to sensitive organs and potentially increase the chance of secondary cancers and, therefore, needs to be managed.AimsThis task group was charged with: a) providing an overview on imaging dose, including megavoltage electronic portal imaging (MV EPI), kilovoltage digital radiography (kV DR), Tomotherapy MV‐CT, megavoltage cone‐beam CT (MV‐CBCT) and kilovoltage cone‐beam CT (kV‐CBCT), and b) providing general guidelines for commissioning dose calculation methods and managing imaging dose to patients.Materials & MethodsWe briefly review the dose to radiotherapy (RT) patients resulting from different image guidance procedures and list typical organ doses resulting from MV and kV image acquisition procedures.ResultsWe provide recommendations for managing the imaging dose, including different methods for its calculation, and techniques for reducing it. The recommended threshold beyond which imaging dose should be considered in the treatment planning process is 5% of the therapeutic target dose.DiscussionAlthough the imaging dose resulting from current kV acquisition procedures is generally below this threshold, the ALARA principle should always be applied in practice. Medical physicists should make radiation oncologists aware of the imaging doses delivered to patients under their care.ConclusionBalancing ALARA with the requirement for effective target localization requires that imaging dose be managed based on the consideration of weighing risks and benefits to the patient.
Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease
Law, Cindy C Y , Narula, Alisha, McKenna, Nicholas P. , Narula, Neeraj , Lightner, Amy L. , Colombel, Jean‐Frédéric , McKenna, Nicholas P

Mayo Clinic

Journal of Crohn's and Colitis | February 22, 2018 | Volume: 12 | Issue: 5 | Pages: 538-545

10.1093/ecco-jcc/jjy022 | PMID 29718245 Get It

Association between smoking and risk of primary sclerosing cholangitis: A systematic review and meta‐analysis
Wijarnpreecha, Karn , Panjawatanan, Panadeekarn , Mousa, Omar Y. , Cheungpasitporn, Wisit , Pungpapong, Surakit , Ungprasert, Patompong , Cheungpasitporn, Wisit , Pungpapong, Surakit , Wijarnpreecha, Karn , Mousa, Omar

Mayo Clinic

United European Gastroenterology Journal | February 22, 2018 | Volume: 6 | Issue: 4 | Pages: 500-508

10.1177/2050640618761703 | PMID 29881604 Get It

Background/ObjectivesStudies have suggested that smokers may have a lower risk of primary sclerosing cholangitis (PSC) although the results have been inconsistent. This systematic review and meta‐analysis was conducted to summarize all available data to better characterize this association.MethodsA comprehensive literature review was conducted using Medline and Embase databases through January 2018 to identify all studies that compared the risk of PSC among current/former smokers versus nonsmokers. Effect estimates from each study were extracted and combined using the random‐effect, generic inverse variance method of DerSimonian and Laird.ResultsSeven case‐control studies with 2,307,393 participants met the eligibility criteria and were included in the meta‐analysis. The risk of PSC among current smokers and former smokers was significantly lower than nonsmokers with the pooled odds ratio of 0.31 (95% CI, 0.18–0.53) and 0.52 (95% CI, 0.44–0.61), respectively. The risk remained significantly lower among current smokers and former smokers compared with nonsmokers even when only patients with PSC without inflammatory bowel disease were included.ConclusionsA significantly decreased risk of PSC among current and former smokers was demonstrated in this study.